(2S)-2-amino-4-[2-aminoethyl-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]amino]butanoic acid

InChIKey	`RPXXFSOUEYJZLT-OPYVMVOTSA-N`
Compound Name	(2S)-2-amino-4-[2-aminoethyl-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]amino]butanoic acid
Canonical SMILES	`NCCN(CC[C@H](N)C(=O)O)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	6.23
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P61964	WDR5	Homo sapiens	Human	PF25175	6.2	IC50	ChEMBL
Q03164	KMT2A	Homo sapiens	Human	PF05965 PF05964 PF00628 PF00856 PF02008 PF13771	6.2	IC50	ChEMBL
Q15291	RBBP5	Homo sapiens	Human	PF00400	6.2	IC50	ChEMBL
Q9C005	DPY30	Homo sapiens	Human	PF05186	6.2	IC50	ChEMBL
Q9UBL3	ASH2L	Homo sapiens	Human	PF21198 PF21257 PF00622	6.2	IC50	ChEMBL